跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CABAZITAXEL FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CABAZITAXEL FOR INJECTION
Authorized
STANDARD
CABAZITAXEL FOR INJECTION
dr reddy's laboratories ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
986d8103cd78b96f
Company
dr reddy's laboratories ltd
Type
Standard
Approval Details
Approval Id
986d8103cd78b96f
Drug Approval Canada Name
CABAZITAXEL FOR INJECTION
Product Name
CABAZITAXEL FOR INJECTION
Status
Marketed
Status Date
2020-06-01
Original Market Date
2020-06-01
Din
02495635
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01CD04 CABAZITAXEL
Atc Name
l 01 cd 04
Aig Number
0152936001
Company Name
dr reddy's laboratories ltd
Company Address
Survey Nos. 42, 45, 46 & 54, Innovation Plaza, Bachupally, Medchal-Malkajgiri, Telangana, India, 500090
Active Ingredients
CABAZITAXEL
40 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
986d8103cd78b96f
Type
Standard
Back to Health Canada Approvals